Clinical Trial Update: Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers [Phase 3]

View source ↗

Summary

Phase 3 study of an investigational MenACYW Conjugate Vaccine evaluating 5- and/or 10-year booster doses in children and adolescents who were vaccinated as todd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenACYW Conjugate Vaccine (MenACWY conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-08